Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 • 5,683 citations
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
2003 • 1,623 citations
The Central Role of CD4+ T Cells in the Antitumor Immune Response
1998 • 1,332 citations
The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes
1999 • 574 citations
CD4+T cells eliminate MHC class II-negative cancer cellsin vivoby indirect effects of IFN-γ
1999 • 378 citations
Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer
2005 • 352 citations
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma
2001 • 271 citations
An investigational new drug treatment program for patients with gemcitabine
1999 • 265 citations
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
2000 • 259 citations
Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes
2004 • 254 citations
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
2006 • 233 citations
CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination
2003 • 192 citations
Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
1997 • 163 citations
Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections
1999 • 153 citations
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy
2004 • 126 citations
HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy
2002 • 121 citations
Identification of human telomerase reverse transcriptase–derived peptides that induce HLA-A24–restricted antileukemia cytotoxic T lymphocytes
2001 • 117 citations
Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase
2004 • 111 citations
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy
2004 • 107 citations
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
2001 • 103 citations
Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
2002 • 95 citations
Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells
2002 • 92 citations
Diagnosis of Pancreatic Cancer by Detecting Telomerase Activity in Pancreatic Juice: Comparison With K- Ras Mutations
1999 • 88 citations
Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes.
2003 • 76 citations
Is selection for TCR affinity a factor in cytokine polarization?
2002 • 69 citations
Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A
2001 • 53 citations
IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation
2003 • 49 citations
Telomerase activity in human solid tumors. Diagnostic utility and clinical applications.
1999 • 44 citations
Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer
1998 • 44 citations
Telomerase as a possible target for anticancer therapy
1999 • 33 citations
Rejection of Intraocular Tumors by CD4+ T Cells Without Induction of Phthisis
2001 • 32 citations
Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells
1999 • 26 citations